Want to see AU:RCE full AI Analyst Report?
Recce Pharmaceuticals Ltd. (RCE) Income Statement
23 Followers
Recce Pharmaceuticals Ltd. Income Statement
Last quarter (Q4 2026), Recce Pharmaceuticals Ltd.'s total revenue was AU$0.00, a decrease of 100.00% from the same quarter last year. In Q4, Recce Pharmaceuticals Ltd.'s net income was AU$1.60M. See Recce Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| AU$ 0.00 | AU$ 7.51M | AU$ 5.03M | AU$ 4.37M | AU$ 3.08M | |
| AU$ -356.40K | AU$ -2.94M | AU$ -2.19M | AU$ 4.15M | AU$ 2.90M | |
| AU$ 22.81M | AU$ 19.94M | AU$ 21.68M | AU$ 17.11M | AU$ 13.96M | |
| Depreciation and Amortization | AU$ 356.40K | AU$ 356.16K | AU$ 366.77K | AU$ 217.16K | AU$ 187.67K |
| AU$ -22.81M | AU$ -20.05M | AU$ -21.35M | AU$ -16.99M | AU$ -13.87M | |
| AU$ -23.16M | AU$ -22.88M | AU$ -22.05M | AU$ -17.33M | AU$ -14.15M | |
| AU$ -677.39K | AU$ 1.45M | AU$ -516.49K | AU$ -63.06K | AU$ 79.07K | |
| AU$ -23.84M | AU$ -21.43M | AU$ -22.57M | AU$ -17.39M | AU$ -14.07M | |
| AU$ -14.96M | AU$ -21.43M | AU$ -17.66M | AU$ -13.08M | AU$ -10.99M | |
| Per Share Metrics | |||||
| Basic EPS | AU$ -0.05 | AU$ -0.09 | AU$ -0.10 | AU$ -0.07 | AU$ -0.06 |
| Diluted EPS | AU$ -0.05 | AU$ -0.09 | AU$ -0.10 | AU$ -0.07 | AU$ -0.06 |
| Weighted Average Shares Outstanding | 289.15M | 236.98M | 177.10M | 175.71M | 175.87M |
| Weighted Average Shares Outstanding (Diluted) | 289.15M | 236.98M | 177.10M | 175.71M | 175.87M |
Currency in AUD
